PRLD / Prelude Therapeutics Incorporated - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Prelude Therapeutics Incorporated
US ˙ NasdaqGS ˙ US74065P1012

Utestående aktier 43,750,086 shares
Insideraktier35 531 914 shares
Insynsägande81,22 %
Totalt antal insynspersoner21
Insider Sentiment Score

Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.

Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.

Uppdateringsfrekvens: Dagligen

Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.

Office Sentiment Score

Officersentiment Score hittar företag som köps av Corporate Officers.

Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.

Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.

Uppdateringsfrekvens: Dagligen

Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.

Viktiga insidernyckeltal

Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.

Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).

Nettoantalet insiders som köper (rankning)

0 ( )

1600 out of 11307

Nettoantalet insiders som köper är den totala mängden insiders som säljer minus det totala antalet insiders som säljer under de senaste 90 dagarna. Percentilrankningen visas här (intervall från 0 till 100%).

Procent av flytande köpta av insiders (ranking)

0.000 %( )

1576 out of 11220

Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.

Insiderhandelsdiagram

Prelude Therapeutics Incorporated insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.

Insiderlista och lönsamhetsstatistik

Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.

See our leaderboard of most profitable insider traders.

Insider Genomsnitt vinst (%) Aktier
Ägda
Delad
Justerad
Baker Bros. Advisors Lp Director, 10% Owner - [D] [10%] 9 252 951 9 252 951
Julian Baker Director, 10% Owner - [D] [10%] 9 252 951 9 252 951
Martin Babler 36 400
David P Bonita Director, 10% Owner - [D] [10%] 10 646 056 10 646 056
Laurent Chardonnet Chief Financial Officer - [O] 42 165 42 165
Andrew Combs Chief Chemistry Officer - [O] 480 123 480 123
Mardi Dier Director - [D] 10 000 10 000
Insider Genomsnitt vinst (%) Aktier
Ägda
Delad
Justerad
Paul A Friedman Director - [D] 500 098 500 098
Jane Huang President, CMO - [O] 80 897 80 897
Bryant David Lim CLO, Interim CFO, Corp Sec. - [O] 27 400 27 400
David J Mauro Chief Medical Officer - [O] 0 0
Deborah Morosini EVP, Chief of Clinical Affairs - [O] 444 444
Kelvin Neu 0
Orbimed Advisors Llc Director, 10% Owner - [D] [10%] 10 646 056 10 646 056
Insider Genomsnitt vinst (%) Aktier
Ägda
Delad
Justerad
Orbimed Capital Llc Director, 10% Owner - [D] [10%] 5 596 886 10 646 056
OrbiMed Capital GP VI LLC Director, 10% Owner - [D] [10%] 5 596 886 10 646 056
Christopher Pierce EVP and Chief of Business Oper - [O] 3 750 3 750
Brian Piper Chief Financial Officer - [O] 0 0
Victor Sandor 11 206
Peggy Scherle Chief Scientific Officer - [O] 172 920 172 920
Krishna Vaddi CEO, Director - [D] [O] 3 669 054 3 669 054

Report errors via our new Insider Auditing Tool

Track Records av insiderköp - Kortsiktig vinstanalys

I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i PRLD / Prelude Therapeutics Incorporated. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.

Handelsdatum Insider Rapporterade
aktier
Rapporterat
pris
Justerade
aktier
Justerat
pris
Kostnadsbasis Dagar til
Max
Pris vid
Max
Maximal
vinst ($)
Maximal avkastning (%)
2025-03-25 Combs Andrew 100 000 0,6925 100 000 0,6925 69 250 156 1.3100 61 750 89,17
2025-03-25 Vaddi Krishna 675 000 0,6925 675 000 0,6925 467 438
2025-03-21 Vaddi Krishna 15 000 0,7306 15 000 0,7306 10 959
2025-03-20 Vaddi Krishna 5 416 0,7294 5 416 0,7294 3 950
2025-03-17 Vaddi Krishna 9 106 0,7499 9 106 0,7499 6 829
2025-03-14 Vaddi Krishna 29 999 0,7544 29 999 0,7544 22 631
2025-03-13 Vaddi Krishna 50 000 0,7164 50 000 0,7164 35 820
2025-03-12 Vaddi Krishna 47 500 0,7104 47 500 0,7104 33 744
2024-12-31 Vaddi Krishna 5 000 1,2087 5 000 1,2087 6 044

Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.

PRLD / Prelude Therapeutics Incorporated Insider Trades
Track Records av insiderförsäljning - Kortsiktig förlustanalys

I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i PRLD / Prelude Therapeutics Incorporated. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.

Handelsdatum Insider Rapporterade
aktier
Rapporterat
pris
Justerade
aktier
Justerat
pris
Kostnadsbasis Dagar til
Min
Pris vid
Min
Maximal förlust
undvikits ($)
Maximal förlust
undvikits ($)
2023-04-06 Huang Jane 13 280 6,1200 13 280 6,1200 81 274 208 1.6900 −58 830 −72,39

Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.

PRLD / Prelude Therapeutics Incorporated Insider Trades
Transaktionshistorik

Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.

Fil
datum
Handel
datum
Schema Insider Ticker Värdepappertitel Kod 10b5-1 Direkta Utövningspris Enhet
pris
Enheter
ändrad
Värde
ändrad (1K)
Kvarvarande
Optioner
Kvarvarande
Aktier
2025-07-08 2025-07-04 4 Huang Jane PRLD Common Stock F - Taxes D 0,7939 −3 355 −3 80 897
2025-07-08 2025-07-04 4 Huang Jane PRLD Common Stock M - Exercise D 9 375 84 252
2025-04-07 2025-04-04 4 Huang Jane PRLD Common Stock F - Taxes D 0,6750 −3 355 −2 74 877
2025-04-07 2025-04-04 4 Huang Jane PRLD Common Stock M - Exercise D 9 375 78 232
2025-03-27 2025-03-25 4 Combs Andrew PRLD Common Stock P - Purchase D 0,6925 100 000 69 480 123
2025-03-27 2025-03-25 4 Vaddi Krishna PRLD Common Stock P - Purchase D 0,6925 675 000 467 1 999 296
2025-03-24 2025-03-21 4 Vaddi Krishna PRLD Common Stock P - Purchase D 0,7306 15 000 11 1 324 296
2025-03-24 2025-03-20 4 Vaddi Krishna PRLD Common Stock P - Purchase D 0,7294 5 416 4 1 309 296
2025-03-18 2025-03-17 4 Vaddi Krishna PRLD Common Stock P - Purchase D 0,7499 9 106 7 1 303 880
2025-03-18 2025-03-14 4 Vaddi Krishna PRLD Common Stock P - Purchase D 0,7544 29 999 23 1 294 774
2025-03-14 2025-03-13 4 Vaddi Krishna PRLD Common Stock P - Purchase D 0,7164 50 000 36 1 264 775
2025-03-14 2025-03-12 4 Vaddi Krishna PRLD Common Stock P - Purchase D 0,7104 47 500 34 1 214 775
2025-01-07 2025-01-04 4 Huang Jane PRLD Common Stock F - Taxes D 1,3900 −3 859 −5 68 857
2025-01-07 2025-01-04 4 Huang Jane PRLD Common Stock M - Exercise D 9 375 72 716
2025-01-03 2024-12-31 4 Vaddi Krishna PRLD Common Stock P - Purchase I 1,2087 5 000 6 142 553
2025-01-02 2024-12-30 4 Vaddi Krishna PRLD Common Stock P - Purchase I 1,2000 10 000 12 137 553
2024-12-26 2024-12-23 4 Combs Andrew PRLD Common Stock P - Purchase D 1,3667 60 000 82 377 623
2024-12-26 2024-12-20 4 Combs Andrew PRLD Common Stock P - Purchase D 1,1500 3 075 4 317 623
2024-12-20 2024-12-19 4 Lim Bryant David PRLD Common Stock P - Purchase D 0,9055 25 000 23 27 400
2024-12-20 2024-12-19 4 Vaddi Krishna PRLD Common Stock P - Purchase I 0,8879 6 888 6 127 553
2024-12-20 2024-12-18 4 Vaddi Krishna PRLD Common Stock P - Purchase D 0,9321 100 000 93 1 167 275
2024-10-07 2024-10-04 4 Huang Jane PRLD Common Stock F - Taxes D 2,0000 −3 349 −7 63 341
2024-10-07 2024-10-04 4 Huang Jane PRLD Common Stock M - Exercise D 9 375 66 690
2024-07-08 2024-07-04 4 Huang Jane PRLD Common Stock F - Taxes D 3,6000 −3 347 −12 57 315
2024-07-08 2024-07-04 4 Huang Jane PRLD Common Stock M - Exercise D 9 375 60 662
2024-04-08 2024-04-04 4 Huang Jane PRLD Common Stock F - Taxes D 4,7400 −3 347 −16 51 287
2024-04-08 2024-04-04 4 Huang Jane PRLD Common Stock M - Exercise D 9 375 54 634
2024-01-08 2024-01-04 4 Huang Jane PRLD Common Stock F - Taxes D 3,7700 −3 844 −14 45 259
2024-01-08 2024-01-04 4 Huang Jane PRLD Common Stock M - Exercise D 9 375 49 103
2023-10-06 2023-10-04 4 Huang Jane PRLD Common Stock M - Exercise D 9 375 39 728
2023-07-06 2023-07-04 4 Huang Jane PRLD Common Stock F - Taxes D 4,6500 −3 242 −15 30 353
2023-07-06 2023-07-04 4 Huang Jane PRLD Common Stock M - Exercise D 9 375 33 595
2023-05-26 2023-05-25 4 Vaddi Krishna PRLD Common Stock P - Purchase D 5,3100 900 5 1 067 275
2023-05-26 2023-05-24 4 Vaddi Krishna PRLD Common Stock P - Purchase D 5,0114 1 000 5 1 066 375
2023-05-25 2023-05-23 4 Chardonnet Laurent PRLD Common Stock P - Purchase D 5,5000 5 000 28 42 165
2023-05-25 2023-05-24 4 Lim Bryant David PRLD Common Stock P - Purchase D 5,3900 2 400 13 2 400
2023-05-25 2023-05-23 4 Vaddi Krishna PRLD Common Stock P - Purchase D 5,6300 11 856 67 1 065 375
2023-05-24 2023-05-22 4 ORBIMED ADVISORS LLC See footnotes PRLD Common Stock P - Purchase I 5,7500 869 565 5 000 10 119 756
2023-05-24 2023-05-22 4 Bonita David P See footnotes PRLD Common Stock P - Purchase I 5,7500 869 565 5 000 10 119 756
2023-04-06 2023-04-06 4 Huang Jane PRLD Common Stock S - Sale D 6,1200 −13 280 −81 24 220
2023-04-06 2023-04-04 4 Huang Jane PRLD Common Stock M - Exercise D 37 500 37 500
2022-12-21 2022-12-20 4 Vaddi Krishna PRLD Common Stock P - Purchase I 5,1306 19 188 98 120 665
2022-12-12 2022-12-08 4 Chardonnet Laurent PRLD Common Stock P - Purchase D 4,7600 10 000 48 35 873
2022-06-01 2022-06-01 4 Chardonnet Laurent PRLD Common Stock P - Purchase D 4,2300 10 000 42 24 500
2022-05-04 2022-05-02 4 Huang Jane PRLD Restricted Stock Unit A - Award D 150 000 150 000
2022-05-04 2022-05-02 4 Huang Jane PRLD Employee Stock Option (Right to Buy) A - Award D 4,86 460 000 460 000
2022-04-04 2022-04-01 4 Combs Andrew PRLD Employee Stock Option (right to buy) M - Exercise D 1,89 −36 062 50 397
2022-04-04 2022-03-31 4 Combs Andrew PRLD Common Stock M - Exercise D 1,8900 36 062 68 304 442
2022-03-22 2022-03-21 4 Chardonnet Laurent PRLD Common Stock A - Award D 7,5100 6 500 49 14 500
2022-02-17 2022-02-15 4 Chardonnet Laurent PRLD Employee Stock Option (right to buy) A - Award D 10,58 90 000 90 000
2022-02-17 2022-02-15 4 Scherle Peggy PRLD Employee Stock Option (right to buy) A - Award D 10,58 100 000 100 000
2022-02-17 2022-02-15 4 Morosini Deborah PRLD Employee Stock Option (right to buy) A - Award D 10,58 90 000 90 000
2022-02-17 2022-02-15 4 Vaddi Krishna PRLD Employee Stock Option (right to buy) A - Award D 10,58 327 900 327 900
2022-02-17 2022-02-15 4 Combs Andrew PRLD Employee Stock Option (right to buy) A - Award D 10,58 100 000 100 000
2022-01-05 2022-01-03 4 Sandor Victor PRLD Director Stock Option (Right to Buy) A - Award D 13,22 11 206 11 206
2021-12-17 2021-12-15 4 Morosini Deborah PRLD Employee Stock Option (right to buy) M - Exercise D 12,85 −882 195 163
2021-12-17 2021-12-15 4 Morosini Deborah PRLD Employee Stock Option (right to buy) M - Exercise D 12,85 −24 853 74 575
2021-12-17 2021-12-15 4 Morosini Deborah PRLD Employee Stock Option (right to buy) M - Exercise D 1,89 −3 016 1 307
2021-12-17 2021-12-15 4 Morosini Deborah PRLD Common Stock S - Sale D 13,0000 −28 751 −374 444
2021-12-17 2021-12-15 4 Morosini Deborah PRLD Common Stock M - Exercise D 12,8500 25 735 331 29 195
2021-12-17 2021-12-15 4 Morosini Deborah PRLD Common Stock M - Exercise D 1,8900 3 016 6 3 460
2021-12-15 2021-12-14 4 Combs Andrew PRLD Common Stock P - Purchase D 11,6000 4 000 46 268 380
2021-12-15 2021-12-13 4 Combs Andrew PRLD Common Stock P - Purchase D 12,1200 4 000 48 264 380
2021-12-14 2021-12-13 4 Chardonnet Laurent PRLD Common Stock A - Award D 12,2800 5 000 61 8 000
2021-12-14 2021-12-13 4 Vaddi Krishna PRLD Common Stock A - Award D 12,1294 8 000 97 1 053 519
2021-12-01 2021-11-29 4 Chardonnet Laurent PRLD Employee Stock Option (Right to Buy) A - Award D 13,75 180 000 180 000
2021-12-01 3 Chardonnet Laurent PRLD Common Stock D 3 000
2021-11-18 2021-11-16 4 Morosini Deborah PRLD Employee Stock Option (right to buy) M - Exercise D 12,85 −28 751 196 045
2021-11-18 2021-11-16 4 Morosini Deborah PRLD Common Stock S - Sale D 16,4250 −400 −7 444
2021-11-18 2021-11-16 4 Morosini Deborah PRLD Common Stock S - Sale D 15,8711 −28 351 −450 844
2021-11-18 2021-11-16 4 Morosini Deborah PRLD Common Stock M - Exercise D 12,8500 28 751 369 29 195
2021-10-14 2021-10-13 4 Sandor Victor PRLD Director Stock Option (Right to Buy) A - Award D 15,81 8 022 8 022
2021-10-06 2021-10-05 4 Mauro David J PRLD Employee Stock Option (Right to Buy) M - Exercise D 1,89 −15 000 137 610
2021-10-06 2021-10-05 4 Mauro David J PRLD Common Stock S - Sale D 32,0637 −1 289 −41 0
2021-10-06 2021-10-05 4 Mauro David J PRLD Common Stock S - Sale D 31,3030 −7 803 −244 1 289
2021-10-06 2021-10-05 4 Mauro David J PRLD Common Stock S - Sale D 30,2577 −5 908 −179 9 092
2021-10-06 2021-10-05 4 Mauro David J PRLD Common Stock M - Exercise D 1,8900 15 000 28 15 000
2021-09-09 2021-09-07 4 Mauro David J PRLD Employee Stock Option (Right to Buy) M - Exercise D 1,89 −15 000 167 610
2021-09-09 2021-09-07 4 Mauro David J PRLD Common Stock S - Sale D 37,7876 −4 640 −175 0
2021-09-09 2021-09-07 4 Mauro David J PRLD Common Stock S - Sale D 36,9234 −2 873 −106 4 640
2021-09-09 2021-09-07 4 Mauro David J PRLD Common Stock S - Sale D 35,9112 −7 487 −269 7 513
2021-09-09 2021-09-07 4 Mauro David J PRLD Common Stock M - Exercise D 1,8900 15 000 28 15 000
2021-09-07 2021-09-02 4 Pierce Christopher PRLD Employee Stock Option (right to buy) M - Exercise D 12,85 −17 000 207 796
2021-09-07 2021-09-02 4 Pierce Christopher PRLD Common Stock S - Sale D 42,4974 −6 930 −295 3 750
2021-09-07 2021-09-02 4 Pierce Christopher PRLD Common Stock S - Sale D 41,5176 −6 727 −279 10 680
2021-09-07 2021-09-02 4 Pierce Christopher PRLD Common Stock S - Sale D 40,2922 −3 343 −135 17 407
2021-09-07 2021-09-02 4 Pierce Christopher PRLD Common Stock M - Exercise D 12,8500 17 000 218 20 750
2021-08-30 2021-08-27 4 Scherle Peggy PRLD Employee Stock Option (Right to Buy) M - Exercise D 1,43 −6 014 27 018
2021-08-30 2021-08-27 4 Scherle Peggy PRLD Common Stock S - Sale D 37,0761 −607 −23 172 920
2021-08-30 2021-08-27 4 Scherle Peggy PRLD Common Stock S - Sale D 36,2340 −2 707 −98 173 527
2021-08-30 2021-08-27 4 Scherle Peggy PRLD Common Stock S - Sale D 35,3247 −2 700 −95 176 234
2021-08-30 2021-08-27 4 Scherle Peggy PRLD Common Stock M - Exercise D 1,4300 6 014 9 178 934
2021-08-30 2021-08-26 4 Scherle Peggy PRLD Employee Stock Option (Right to Buy) M - Exercise D 1,43 −1 700 33 032
2021-08-30 2021-08-26 4 Scherle Peggy PRLD Common Stock S - Sale D 35,1879 −1 700 −60 172 920
2021-08-30 2021-08-26 4 Scherle Peggy PRLD Common Stock M - Exercise D 1,4300 1 700 2 174 620
2021-08-27 2021-08-25 4 Piper Brian PRLD Employee Stock Option (Right to Buy) M - Exercise D 1,89 −8 333 264 329
2021-08-27 2021-08-25 4 Piper Brian PRLD Common Stock S - Sale D 34,3299 −2 344 −80 0
2021-08-27 2021-08-25 4 Piper Brian PRLD Common Stock S - Sale D 33,2308 −3 889 −129 2 344
2021-08-27 2021-08-25 4 Piper Brian PRLD Common Stock S - Sale D 32,4398 −2 100 −68 6 233
2021-08-27 2021-08-25 4 Piper Brian PRLD Common Stock M - Exercise D 1,8900 8 333 16 8 333
2021-08-17 2021-08-13 4 Scherle Peggy PRLD Employee Stock Option (Right to Buy) M - Exercise D 1,43 −1 728 34 732
2021-08-17 2021-08-13 4 Scherle Peggy PRLD Employee Stock Option (Right to Buy) M - Exercise D 1,89 −558 42 672
2021-08-17 2021-08-13 4 Scherle Peggy PRLD Common Stock S - Sale D 35,0662 −2 286 −80 172 920
2021-08-17 2021-08-13 4 Scherle Peggy PRLD Common Stock M - Exercise D 1,4300 1 728 2 175 206
2021-08-17 2021-08-13 4 Scherle Peggy PRLD Common Stock M - Exercise D 1,8900 558 1 173 478
2021-08-09 2021-08-05 4 Mauro David J PRLD Employee Stock Option (Right to Buy) M - Exercise D 1,89 −15 000 167 610
2021-08-09 2021-08-05 4 Mauro David J PRLD Common Stock S - Sale D 32,6300 −100 −3 0
2021-08-09 2021-08-05 4 Mauro David J PRLD Common Stock S - Sale D 32,1457 −6 721 −216 100
2021-08-09 2021-08-05 4 Mauro David J PRLD Common Stock S - Sale D 31,0278 −2 063 −64 6 821
2021-08-09 2021-08-05 4 Mauro David J PRLD Common Stock S - Sale D 29,9329 −6 116 −183 8 884
2021-08-09 2021-08-05 4 Mauro David J PRLD Common Stock M - Exercise D 1,8900 15 000 28 15 000
2021-07-29 2021-07-27 4 Scherle Peggy PRLD Employee Stock Option (Right to Buy) M - Exercise D 1,43 −20 000 36 460
2021-07-29 2021-07-27 4 Scherle Peggy PRLD Common Stock S - Sale D 36,0882 −680 −25 172 920
2021-07-29 2021-07-27 4 Scherle Peggy PRLD Common Stock S - Sale D 35,4472 −19 320 −685 173 600
2021-07-29 2021-07-27 4 Scherle Peggy PRLD Common Stock M - Exercise D 1,4300 20 000 29 192 920
2021-07-22 2021-07-20 4 Scherle Peggy PRLD Employee Stock Option (Right to Buy) A - Award D 31,23 95 000 95 000
2021-07-22 2021-07-20 4 Vaddi Krishna PRLD Employee Stock Option (Right to Buy) A - Award D 31,23 285 800 285 800
2021-07-22 2021-07-20 4 Morosini Deborah PRLD Employee Stock Option (Right to Buy) A - Award D 31,23 85 000 85 000
2021-07-22 2021-07-20 4 Mauro David J PRLD Employee Stock Option (Right to Buy) A - Award D 31,23 95 000 95 000
2021-07-22 2021-07-20 4 Pierce Christopher PRLD Employee Stock Option (Right to Buy) A - Award D 31,23 85 000 85 000
2021-07-22 2021-07-20 4 Piper Brian PRLD Employee Stock Option (Right to Buy) A - Award D 31,23 115 650 115 650
2021-07-22 2021-07-20 4 Combs Andrew PRLD Employee Stock Option (Right to Buy) A - Award D 31,23 95 000 95 000
2021-07-20 2021-07-19 4 Babler Martin PRLD Employee Stock Option (Right to Buy) A - Award D 31,37 36 400 36 400
2021-07-08 2021-07-06 4 Mauro David J PRLD Employee Stock Option (Right to Buy) M - Exercise D 1,89 −15 000 182 610
2021-07-08 2021-07-06 4 Mauro David J PRLD Common Stock S - Sale D 28,8433 −300 −9 0
2021-07-08 2021-07-06 4 Mauro David J PRLD Common Stock S - Sale D 28,1343 −4 255 −120 300
2021-07-08 2021-07-06 4 Mauro David J PRLD Common Stock S - Sale D 27,1654 −10 445 −284 4 555
2021-07-08 2021-07-06 4 Mauro David J PRLD Common Stock M - Exercise D 1,8900 15 000 28 15 000
2021-06-22 2021-06-18 4 Sandor Victor PRLD Director Stock Option (Right to Buy) A - Award D 31,02 23 344 23 344
2021-06-22 2021-06-18 4 FRIEDMAN PAUL A PRLD Director Stock Option (Right to Buy) A - Award D 31,02 23 344 23 344
2021-06-22 2021-06-18 4 Dier Mardi PRLD Director Stock Option (Right to Buy) A - Award D 31,02 23 344 23 344
2021-06-22 2021-06-18 4 Bonita David P PRLD Director Stock Option (Right to Buy) A - Award D 31,02 23 344 23 344
2021-06-22 2021-06-18 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Non-Qualified Stock Options (right to buy) A - Award I 31,02 23 344 23 344
2021-06-09 2021-06-07 4 Mauro David J PRLD Common Stock M - Exercise D 1,89 −15 000 197 610
2021-06-09 2021-06-07 4 Mauro David J PRLD Common Stock S - Sale D 32,7295 −12 700 −416 0
2021-06-09 2021-06-07 4 Mauro David J PRLD Common Stock S - Sale D 31,6244 −900 −28 12 700
2021-06-09 2021-06-07 4 Mauro David J PRLD Common Stock S - Sale D 30,3541 −1 400 −42 13 600
2021-06-09 2021-06-07 4 Mauro David J PRLD Common Stock M - Exercise D 1,8900 15 000 28 15 000
2021-05-27 2021-05-25 4 Piper Brian PRLD Employee Stock Option (Right to Buy) M - Exercise D 1,89 −8 333 272 662
2021-05-27 2021-05-25 4 Piper Brian PRLD Common Stock S - Sale D 36,0930 −399 −14 0
2021-05-27 2021-05-25 4 Piper Brian PRLD Common Stock S - Sale D 35,4469 −1 736 −62 399
2021-05-27 2021-05-25 4 Piper Brian PRLD Common Stock S - Sale D 34,1119 −3 088 −105 2 135
2021-05-27 2021-05-25 4 Piper Brian PRLD Common Stock S - Sale D 33,5250 −3 110 −104 5 223
2021-05-27 2021-05-25 4 Piper Brian PRLD Common Stock M - Exercise D 1,8900 8 333 16 8 333
2021-05-11 2021-05-07 4 Scherle Peggy PRLD Employee Stock Option (right to buy) M - Exercise D 1,43 −10 000 56 460
2021-05-11 2021-05-07 4 Scherle Peggy PRLD Common Stock S - Sale D 41,8500 −200 −8 172 920
2021-05-11 2021-05-07 4 Scherle Peggy PRLD Common Stock S - Sale D 41,1395 −5 836 −240 173 120
2021-05-11 2021-05-07 4 Scherle Peggy PRLD Common Stock S - Sale D 40,2957 −3 964 −160 178 956
2021-05-11 2021-05-07 4 Scherle Peggy PRLD Common Stock M - Exercise D 1,4300 10 000 14 182 920
2021-05-10 2021-05-05 4 Mauro David J PRLD Common Stock M - Exercise D 1,89 −15 000 212 610
2021-05-10 2021-05-05 4 Mauro David J PRLD Common Stock S - Sale D 41,0682 −1 109 −46 0
2021-05-10 2021-05-05 4 Mauro David J PRLD Common Stock S - Sale D 40,2967 −10 476 −422 1 109
2021-05-10 2021-05-05 4 Mauro David J PRLD Common Stock S - Sale D 39,3555 −3 415 −134 11 585
2021-05-10 2021-05-05 4 Mauro David J PRLD Common Stock M - Exercise D 1,8900 15 000 28 15 000
2021-04-30 2021-04-29 4 Pierce Christopher PRLD Employee Stock Option (right to buy) M - Exercise D 1,89 −3 295 4 323
2021-04-30 2021-04-29 4 Pierce Christopher PRLD Common Stock S - Sale D 40,2928 −3 295 −133 3 750
2021-04-30 2021-04-29 4 Pierce Christopher PRLD Common Stock M - Exercise D 1,8900 3 295 6 7 045
2021-04-30 2021-04-29 4 Morosini Deborah PRLD Employee Stock Option (right to buy) M - Exercise D 1,89 −3 223 4 323
2021-04-30 2021-04-29 4 Morosini Deborah PRLD Common Stock S - Sale D 40,2896 −3 223 −130 444
2021-04-30 2021-04-29 4 Morosini Deborah PRLD Common Stock M - Exercise D 1,8900 3 223 6 3 667
2021-04-29 2021-04-27 4 Mauro David J PRLD Employee Stock Option (right to buy) M - Exercise D 1,89 −25 000 227 610
2021-04-29 2021-04-27 4 Mauro David J PRLD Common Stock S - Sale D 36,1137 −1 711 −62 0
2021-04-29 2021-04-27 4 Mauro David J PRLD Common Stock S - Sale D 35,6759 −15 601 −557 1 711
2021-04-29 2021-04-27 4 Mauro David J PRLD Common Stock S - Sale D 34,6615 −7 688 −266 17 312
2021-04-29 2021-04-27 4 Mauro David J PRLD Common Stock M - Exercise D 1,8900 25 000 47 25 000
2021-04-21 2021-04-19 4 Mauro David J PRLD Employee Stock Option (right to buy) M - Exercise D 1,89 −25 000 252 610
2021-04-21 2021-04-19 4 Mauro David J PRLD Common Stock S - Sale D 31,2692 −4 000 −125 0
2021-04-21 2021-04-19 4 Mauro David J PRLD Common Stock S - Sale D 30,8225 −21 000 −647 4 000
2021-04-21 2021-04-19 4 Mauro David J PRLD Common Stock M - Exercise D 1,8900 25 000 47 25 000
2021-04-15 2021-04-08 4 Scherle Peggy PRLD Employee Stock Option (right to buy) M - Exercise D 1,43 −4 630 66 460
2021-04-15 2021-04-08 4 Scherle Peggy PRLD Common Stock S - Sale D 39,5688 −1 669 −66 172 920
2021-04-15 2021-04-08 4 Scherle Peggy PRLD Common Stock S - Sale D 38,9726 −669 −26 174 589
2021-04-15 2021-04-08 4 Scherle Peggy PRLD Common Stock S - Sale D 37,7182 −875 −33 175 258
2021-04-15 2021-04-08 4 Scherle Peggy PRLD Common Stock S - Sale D 36,9707 −1 417 −52 176 133
2021-04-15 2021-04-08 4 Scherle Peggy PRLD Common Stock A - Award D 1,4300 4 630 7 177 550
2021-04-15 2021-04-08 4 Pierce Christopher PRLD Employee Stock Option (right to buy) M - Exercise D 1,89 −200 7 618
2021-04-15 2021-04-08 4 Pierce Christopher PRLD Common Stock S - Sale D 40,0000 −200 −8 3 750
2021-04-15 2021-04-08 4 Pierce Christopher PRLD Common Stock A - Award D 1,8900 200 0 3 950
2021-04-15 2021-04-08 4 Morosini Deborah PRLD Employee Stock Option (right to buy) M - Exercise D 1,89 −100 7 546
2021-04-15 2021-04-08 4 Morosini Deborah PRLD Common Stock S - Sale D 40,0000 −100 −4 444
2021-04-15 2021-04-08 4 Morosini Deborah PRLD Common Stock M - Exercise D 1,8900 100 0 544
2021-04-15 2021-04-08 4 Mauro David J PRLD Employee Stock Option (right to buy) M - Exercise D 1,89 −9 617 277 610
2021-04-15 2021-04-08 4 Mauro David J PRLD Common Stock S - Sale D 39,5584 −3 549 −140 0
2021-04-15 2021-04-08 4 Mauro David J PRLD Common Stock S - Sale D 38,9972 −1 293 −50 3 549
2021-04-15 2021-04-08 4 Mauro David J PRLD Common Stock S - Sale D 37,8283 −1 501 −57 4 842
2021-04-15 2021-04-08 4 Mauro David J PRLD Common Stock S - Sale D 37,0360 −3 274 −121 6 343
2021-04-15 2021-04-08 4 Mauro David J PRLD Common Stock M - Exercise D 1,8900 9 617 18 9 617
2021-04-09 2021-04-07 4 Scherle Peggy PRLD Employee Stock Option (right to buy) M - Exercise D 1,43 −15 370 71 090
2021-04-09 2021-04-07 4 Scherle Peggy PRLD Common Stock S - Sale D 40,3000 −200 −8 172 920
2021-04-09 2021-04-07 4 Scherle Peggy PRLD Common Stock S - Sale D 39,6278 −6 881 −273 173 120
2021-04-09 2021-04-07 4 Scherle Peggy PRLD Common Stock S - Sale D 39,0162 −8 289 −323 180 001
2021-04-09 2021-04-07 4 Scherle Peggy PRLD Common Stock A - Award D 1,4300 15 370 22 188 290
2021-04-09 2021-04-07 4 Pierce Christopher PRLD Employee Stock Option (right to buy) M - Exercise D 1,89 −828 7 818
2021-04-09 2021-04-07 4 Pierce Christopher PRLD Common Stock S - Sale D 40,0826 −828 −33 3 750
2021-04-09 2021-04-07 4 Pierce Christopher PRLD Common Stock A - Award D 1,8900 828 2 4 578
2021-04-09 2021-04-07 4 Morosini Deborah PRLD Employee Stock Option (right to buy) M - Exercise D 1,89 −1 000 7 646
2021-04-09 2021-04-07 4 Morosini Deborah PRLD Common Stock S - Sale D 40,0430 −1 000 −40 444
2021-04-09 2021-04-07 4 Morosini Deborah PRLD Common Stock M - Exercise D 1,8900 1 000 2 1 444
2021-04-09 2021-04-07 4 Mauro David J PRLD Employee Stock Option (right to buy) M - Exercise D 1,89 −15 383 287 227
2021-04-09 2021-04-07 4 Mauro David J PRLD Common Stock S - Sale D 39,6888 −7 083 −281 0
2021-04-09 2021-04-07 4 Mauro David J PRLD Common Stock S - Sale D 39,0250 −8 300 −324 7 083
2021-04-09 2021-04-07 4 Mauro David J PRLD Common Stock M - Exercise D 1,8900 15 383 29 15 383
2021-01-29 2021-01-27 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Non-Qualified Stock Options (right to buy) M - Exercise I 12,85 −5 188 41 500
2021-01-29 2021-01-27 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Non-Qualified Stock Options (right to buy) M - Exercise I 12,85 −5 188 41 500
2021-01-29 2021-01-27 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Common Stock M - Exercise I 12,8500 5 188 67 9 252 951
2021-01-29 2021-01-27 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Common Stock M - Exercise I 12,8500 5 188 67 9 252 951
2021-01-13 2021-01-11 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Non-Voting Common Stock P - Purchase I 60,0000 154 222 9 253 5 212 371
2021-01-13 2021-01-11 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Non-Voting Common Stock P - Purchase I 60,0000 12 444 747 509 480
2021-01-12 2021-01-11 4 ORBIMED ADVISORS LLC See Footnotes PRLD Non-Voting Common Stock P - Purchase I 60,0000 41 700 2 502 5 596 886
2021-01-12 2021-01-11 4 Bonita David P See Footnotes PRLD Non-Voting Common Stock P - Purchase I 60,0000 41 700 2 502 5 596 886
2020-09-30 2020-08-21 4/A ORBIMED ADVISORS LLC PRLD Series C Preferred Stock P - Purchase I 1 033 084 1 033 084
2020-09-30 2020-03-27 4/A ORBIMED ADVISORS LLC PRLD Series B Preferred Stock P - Purchase I 3 681 822 7 363 644
2020-09-30 2020-09-29 4 FRIEDMAN PAUL A PRLD Series B Preferred Stock C - Conversion D −152 576 0
2020-09-30 2020-09-29 4 FRIEDMAN PAUL A PRLD Series A Preferred Stock C - Conversion D −295 794 0
2020-09-30 2020-09-29 4 FRIEDMAN PAUL A PRLD Common Stock C - Conversion D 152 576 500 098
2020-09-30 2020-09-29 4 FRIEDMAN PAUL A PRLD Common Stock C - Conversion D 295 794 347 522
2020-09-30 2020-03-27 4 FRIEDMAN PAUL A PRLD Series B Preferred Stock P - Purchase D 76 288 152 576
2020-09-30 2020-09-29 4 Bonita David P PRLD Non-Voting Common Stock C - Conversion I 5 555 186 5 555 186
2020-09-30 2020-09-29 4 Bonita David P PRLD Series C Preferred Stock C - Conversion I −413 234 0
2020-09-30 2020-09-29 4 Bonita David P PRLD Series C Preferred Stock C - Conversion I −619 850 0
2020-09-30 2020-09-29 4 Bonita David P PRLD Series B Preferred Stock C - Conversion I −2 945 458 0
2020-09-30 2020-09-29 4 Bonita David P PRLD Series B Preferred Stock C - Conversion I −4 418 186 0
2020-09-30 2020-09-29 4 Bonita David P PRLD Series A Preferred Stock C - Conversion I −2 196 494 0
2020-09-30 2020-09-29 4 Bonita David P PRLD Series A Preferred Stock C - Conversion I −3 294 743 0
2020-09-30 2020-09-29 4 Bonita David P PRLD Common Stock C - Conversion I 8 332 779 9 250 191
2020-09-30 2020-09-25 4 Bonita David P PRLD Common Stock P - Purchase I 19,0000 710 500 13 500 917 412
2020-09-30 2020-09-25 4 Bonita David P PRLD Common Stock P - Purchase I 19,0000 526 300 10 000 526 300
2020-09-30 2020-09-24 4 Bonita David P PRLD Director Stock Option (right to buy) A - Award D 12,85 46 688 46 688
2020-09-30 2020-08-21 4 Bonita David P PRLD Series C Preferred Stock P - Purchase I 1 033 084 1 033 084
2020-09-30 2020-03-27 4 Bonita David P PRLD Series B Preferred Stock P - Purchase I 3 681 822 7 363 644
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Non-Voting Common Stock C - Conversion I 382 884 5 058 149
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series C Convertible Preferred Stock C - Conversion I −382 884 0
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Non-Voting Common Stock C - Conversion I 30 349 497 036
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series C Convertible Preferred Stock C - Conversion I −30 349 0
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series C Convertible Preferred Stock C - Conversion I −574 327 0
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series C Convertible Preferred Stock C - Conversion I −45 524 0
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Non-Voting Common Stock C - Conversion I 2 698 424 4 675 265
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series B Convertible Preferred Stock C - Conversion I −2 698 424 0
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Non-Voting Common Stock C - Conversion I 247 034 466 687
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series B Convertible Preferred Stock C - Conversion I −247 034 0
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series B Convertible Preferred Stock C - Conversion I −4 047 634 0
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series B Convertible Preferred Stock C - Conversion I −370 552 0
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Non-Voting Common Stock C - Conversion I 1 976 841 1 976 841
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series A Convertible Preferred Stock C - Conversion I −1 976 841 0
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Non-Voting Common Stock C - Conversion I 219 653 219 653
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series A Convertible Preferred Stock C - Conversion I −219 653 0
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series A Convertible Preferred Stock C - Conversion I −2 965 263 0
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series A Convertible Preferred Stock C - Conversion I −329 478 0
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Common Stock P - Purchase I 19,0000 1 474 319 28 012 9 247 763
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Common Stock P - Purchase I 19,0000 104 628 1 988 870 873
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Common Stock C - Conversion I 574 327 7 773 444
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Common Stock C - Conversion I 45 524 766 245
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Common Stock C - Conversion I 4 047 634 7 199 117
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Common Stock C - Conversion I 370 552 720 721
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Common Stock C - Conversion I 2 965 263 3 151 483
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Common Stock C - Conversion I 329 478 350 169
2020-09-30 2020-09-24 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Non-Qualified Stock Option (right to buy) A - Award I 12,85 46 688 46 688
2020-09-30 2020-08-21 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series C Preferred Stock P - Purchase I 14,5196 957 211 13 898 957 211
2020-09-30 2020-08-21 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series C Preferred Stock P - Purchase I 14,5196 75 873 1 102 75 873
2020-09-30 2020-03-27 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series B Preferred Stock P - Purchase I 3,9324 3 373 029 13 264 3 373 029
2020-09-30 2020-03-27 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series B Preferred Stock P - Purchase I 3,9324 308 793 1 214 308 793
2020-09-29 2020-09-29 4 Combs Andrew PRLD Common Stock P - Purchase D 19,0000 1 000 19 260 380
2020-09-29 2020-09-29 4 Vaddi Krishna By Trust PRLD Series A Preferred Stock C - Conversion I −32 876 0
2020-09-29 2020-09-29 4 Vaddi Krishna By Trust PRLD Series A Preferred Stock C - Conversion I −32 876 0
2020-09-29 2020-09-29 4 Vaddi Krishna PRLD Series A Preferred Stock C - Conversion I −101 477 0
2020-09-29 2020-09-29 4 Vaddi Krishna By Trust PRLD Common Stock C - Conversion I 32 876 551 774
2020-09-29 2020-09-29 4 Vaddi Krishna By Trust PRLD Common Stock C - Conversion I 32 876 551 774
2020-09-29 2020-09-29 4 Vaddi Krishna PRLD Common Stock C - Conversion I 101 477 101 477
2020-09-29 2020-09-29 4 Pierce Christopher PRLD Common Stock P - Purchase D 19,0000 3 750 71 3 750
2020-09-29 2020-09-29 4 Morosini Deborah PRLD Common Stock P - Purchase D 19,0000 444 8 444
2020-09-29 2020-09-29 4 Dier Mardi PRLD Common Stock P - Purchase D 19,0000 10 000 190 10 000
2020-09-29 2020-09-29 4 ORBIMED ADVISORS LLC PRLD Non-Voting Common Stock C - Conversion I 5 555 186 5 555 186
2020-09-29 2020-09-29 4 ORBIMED ADVISORS LLC PRLD Series C Preferred Stock C - Conversion I −413 234 0
2020-09-29 2020-09-29 4 ORBIMED ADVISORS LLC PRLD Series C Preferred Stock C - Conversion I −619 850 0
2020-09-29 2020-09-29 4 ORBIMED ADVISORS LLC PRLD Series B Preferred Stock C - Conversion I −2 945 458 0
2020-09-29 2020-09-29 4 ORBIMED ADVISORS LLC PRLD Series B Preferred Stock C - Conversion I −4 418 186 0
2020-09-29 2020-09-29 4 ORBIMED ADVISORS LLC PRLD Series A Prefered Stock C - Conversion I −2 196 494 0
2020-09-29 2020-09-29 4 ORBIMED ADVISORS LLC PRLD Series A Preferred Stock C - Conversion I −3 294 743 0
2020-09-29 2020-09-29 4 ORBIMED ADVISORS LLC PRLD Common Stock C - Conversion I 8 332 779 9 250 191
2020-09-29 2020-09-25 4 ORBIMED ADVISORS LLC PRLD Common Stock P - Purchase I 19,0000 710 500 13 500 917 412
2020-09-29 2020-09-25 4 ORBIMED ADVISORS LLC PRLD Common Stock P - Purchase I 19,0000 526 300 10 000 526 300
2020-09-28 2020-09-24 4 Sandor Victor PRLD Director Stock Option (right to buy) A - Award D 19,00 3 458 3 458
2020-09-28 2020-09-24 4 Dier Mardi PRLD Director Stock Option (right to buy) A - Award D 19,00 3 458 3 458
2020-09-24 3 Scherle Peggy PRLD Common Stock D 172 920
2020-09-24 3 BAKER JULIAN PRLD Common Stock I 186 220
2020-09-24 3 BAKER JULIAN PRLD Common Stock I 20 691
2020-09-24 3 Vaddi Krishna By Trust PRLD Common Stock I 423 655
2020-09-24 3 Vaddi Krishna PRLD Common Stock D 1 045 519
2020-09-24 3 Vaddi Krishna By Trust PRLD Common Stock I 518 898
2020-09-24 3 Vaddi Krishna By Trust PRLD Common Stock I 518 900
2020-09-24 3 OrbiMed Capital GP VI LLC PRLD Common Stock I 206 912
2020-09-24 3 FRIEDMAN PAUL A PRLD Common Stock D 51 728
2020-09-24 3 Combs Andrew PRLD Common Stock D 259 380
2020-09-24 3 Bonita David P See footnotes PRLD Common Stock I 206 912
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista